Neuroplasticity Market Size is valued at USD 7.9 billion in 2024 and is predicted to reach USD 79.2 billion by the year 2034 at a 26.0% CAGR during the forecast period for 2025-2034.
The capacity of the brain to reorganize itself by creating new neural connections as we age is known as neuroplasticity. The brain's neurons may adapt to various circumstances, pick up new skills, and react to environmental changes because of this process. Because it allows the neurons to rearrange themselves and form new connections, neuroplasticity is a crucial component in the brain's ability to recover from damage.
The brain can learn and store new knowledge by adapting to new experiences because of neuroplasticity. The term "plasticity" describes the brain's malleability or capacity for change, not its plasticity. Neuro is short for neurons, the nerve cells that comprise the brain and neurological system. Thus, neuroplasticity enables adjustments or changes in nerve cells.
The term "neuroplasticity" describes how new experiences cause anatomical and functional changes in the brain. The brain can "rewire" and "reorganize" itself after brain trauma because of the plasticity of the brain, also known as neuroplasticity, as new connections are made and neural pathways to injured brain regions are cut off. Known as sprouting and rerouting, these processes are the main drivers of neuroplasticity. The process of sprouting is when nerve cells, or neurons, form new connections.
The high cost of the treatments and therapy is anticipated to hamper the market growth. Stringent regulatory procedures and a lack of reimbursement policies related to treatment hinder the growth of the market. Increasing mobile health applications and digital therapeutics creates opportunities to provide neuroplasticity interventions.
The neuroplasticity market is segmented on the basis of product type, application, and end user. Product type includes software-based solutions and hardware-based solutions. Application segment includes stroke rehabilitation, traumatic brain injury (TBI) rehabilitation, neurodegenerative disorders, learning and memory enhancement, and mental health disorders. On the basis of end users, the market is segmented into hospitals and clinics, research institutes and academic centres, pharmaceutical and biotechnology companies, and others.
The neurodegenerative disorders category is expected to hold a significant share of the global neuroplasticity market in 2022. Neuroplasticity, the brain's capability to reorganize and adapt, is crucial for brain rehabilitation and recovery in persons with neurodegenerative diseases, which is anticipated to drive market growth during the forecast period. New methods and treatments to promote neuroplasticity and recovery in patients with neurodegenerative diseases are anticipated to boost market expansion.
The hospitals and clinics category is projected to improve in the global neuroplasticity market. Increasing treatment related to neurological diseases is anticipated to drive market growth. Furthermore, technological advancements in medicine related to neurological disorders propel the market expansion.
The North America neuroplasticity market is expected to register the highest market share in revenue shortly. Increasing research and development in neuroplasticity treatments will drive market growth. Moreover, key market participants are focusing on acquisitions and mergers, which are driving the growth of the market.
|
Report Attribute |
Specifications |
|
Market size value in 2024 |
USD 7.9 Bn |
|
Revenue forecast in 2034 |
USD 79.2 Bn |
|
Growth rate CAGR |
CAGR of 26.0% from 2025 to 2034 |
|
Quantitative units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments covered |
By Application, Product Type, End-user |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
NeuroSky Inc., Posit Science Corporation, BrainHQ, Synaptitude Brain Health, Mindmaze SA, NeuroVigil Inc., Lumosity, Neuronetics, Inc., CogniFit, BrainHQ, Advanced Brain Monitoring, SharpBrains, Emotiv Inc., BrainCo, BrainHQ, Neuroscape, Neuroplast BV, Reha Technology AG, Virtualware Group, Nexeon Medsystems Inc. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Neuroplasticity Market Snapshot
Chapter 4. Global Neuroplasticity Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product Type:
5.2.1. Software-Based Solutions
5.2.2. Hardware-Based Solutions
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
6.2.1. Stroke Rehabilitation
6.2.2. Traumatic Brain Injury (TBI) Rehabilitation
6.2.3. Neurodegenerative Disorders
6.2.4. Learning and Memory Enhancement
6.2.5. Mental Health Disorders
Chapter 7. Market Segmentation 3: By End-user Estimates & Trend Analysis
7.1. By End-user & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-user:
7.2.1. Hospitals and Clinics
7.2.2. Research Institutes and Academic Centers
7.2.3. Pharmaceutical and Biotechnology Companies
7.2.4. Others
Chapter 8. Neuroplasticity Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts By Product Type, 2021-2034
8.1.2. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.1.3. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
8.1.4. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Neuroplasticity Market revenue (US$ Million) By Product Type, 2021-2034
8.2.2. Europe Neuroplasticity Market revenue (US$ Million) By Application, 2021-2034
8.2.3. Europe Neuroplasticity Market revenue (US$ Million) By End-user, 2021-2034
8.2.4. Europe Neuroplasticity Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Neuroplasticity Market revenue (US$ Million) By Product Type, 2021-2034
8.3.2. Asia Pacific Neuroplasticity Market revenue (US$ Million) By Application, 2021-2034
8.3.3. Asia Pacific Neuroplasticity Market revenue (US$ Million) By End-user, 2021-2034
8.3.4. Asia Pacific Neuroplasticity Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Neuroplasticity Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
8.4.2. Latin America Neuroplasticity Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.4.3. Latin America Neuroplasticity Market revenue (US$ Million) By End-user, (US$ Million) 2021-2034
8.4.4. Latin America Neuroplasticity Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Neuroplasticity Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
8.5.2. Middle East & Africa Neuroplasticity Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.5.3. Middle East & Africa Neuroplasticity Market revenue (US$ Million) By End-user, (US$ Million) 2021-2034
8.5.4. Middle East & Africa Neuroplasticity Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. NeuroSky Inc
9.2.2. Posit Science Corporation
9.2.3. BrainHQ
9.2.4. Synaptitude Brain Health
9.2.5. Mindmaze SA
9.2.6. NeuroVigil Inc
9.2.7. Lumosity
9.2.8. Neuronetics, Inc.
9.2.9. CogniFit, BrainHQ
9.2.10. Advanced Brain Monitoring
9.2.11. SharpBrains
9.2.12. Emotiv Inc
9.2.13. BrainCo
9.2.14. BrainHQ
9.2.15. Neuroscape
9.2.16. Neuroplast BV
9.2.17. Reha Technology AG
9.2.18. Virtualware Group
9.2.19. Nexeon Medsystems Inc.
Neuroplasticity Market By Product Type
Neuroplasticity Market By Application
Neuroplasticity Market By End User
Neuroplasticity Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.4456
